Min Wu
Impact in
-
- Toxic Organic Pollutants Impact
- Air Quality and Health Impacts
- Effects and risks of endocrine disrupting chemicals
- Pollution top 5%
- Microplastics and Plastic Pollution
Papers in
- Urology 8
- Urological Disorders and Treatments 5
- Hematology 12
- Acute Myeloid Leukemia Research 11
- Journals
- Cancers (3 papers)Environment International (3 papers)Blood (3 papers)Oncotarget (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Min Wu
113 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 131
- Health, Toxicology and Mutagenesis 722
- Pollution 210
- Cancer Research 253
- Immunology 227
- Pharmacology 89
Countries citing papers authored by Min Wu
This map shows the geographic impact of Min Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Wu more than expected).
Fields of papers citing papers by Min Wu
This network shows the impact of papers produced by Min Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Wu. The network helps show where Min Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 16 | |
| 14 | 2018 | 58 | |
| 15 | 2018 | 90 | |
| 16 | 2016 | 14 | |
| 17 | 2015 | 20 | |
| 18 | 2014 | 3 | |
| 19 | Analysis on the level of plasma glucose and prevalence of diabetes among residents of Jiangsu province | 2011 | 4 |
| 20 | [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma]. | 2004 | 3 |
About Min Wu
Min Wu is a scholar working on Urology, Hematology, Pharmacology, Dermatology and Cancer Research, having authored 121 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Nanoplatforms for cancer theranostics (8 papers), Air Quality and Health Impacts (8 papers), Toxic Organic Pollutants Impact (7 papers), RNA modifications and cancer (6 papers), Microtubule and mitosis dynamics (5 papers), Computational Drug Discovery Methods (5 papers) and Urological Disorders and Treatments (5 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (722 citations), Pollution (210 citations), Cancer Research (253 citations), Immunology (227 citations) and Pharmacology (89 citations). Min Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Gang Yu, Zhiguo Cao, Jun Huang, Bin Wang, Shubo Deng, Jing Xia, Qingwei Bu, Fuchao Xu, Adrian Covaci and Xinming Du. Their work appears in journals such as Cancers, Environment International, Blood, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.